Joshua M. Bauml, MD, assistant professor, University of Pennsylvania, discusses a novel IT platform designed to enhance lung cancer clinical trial enrollment.
More at onclive.com/
- Dr. Bauml on a New Platform to Enhance Lung Cancer Clinical Trial Enrollment ( Download)
- Dr. Bauml Discusses a New Electronic Platform for Clinical Trial Enrollment in Lung Cancer ( Download)
- Dr. Bauml on the Use of Immunotherapy in Oligometastatic NSCLC ( Download)
- Dr. Bauml Discusses Liquid Biopsies in Lung Cancer ( Download)
- Dr. Bauml on the Utility of Liquid Biopsy in Metastatic NSCLC ( Download)
- Dr. Bauml on KEYNOTE-055 Study for Patients With HNSCC ( Download)
- Dr. Bauml Discusses Immunotherapy in Head and Neck Cancer ( Download)
- Dr. Bauml on Immunotherapy Combinations in Head and Neck Cancer ( Download)
- Dr. Joshua M. Bauml on the Impact of Pembrolizumab in Head and Neck Cancer ( Download)
- Key Insights in Lung Cancer: from the 22nd Annual Perspectives in Thoracic Oncology ( Download)
- Expanding beyond the checkpoints: New vaccines and other immunologic strategies for NSCLC ( Download)
- Nina Bickell, MD, MPH, regarding physician attitudes toward cancer clinical trial enrollment ( Download)
- Possibilities for Using Liquid Biopsies in Lung Cancer ( Download)
- Dr. Bauml Discusses Biomarkers in Head and Neck Cancer ( Download)
- Medical Oncology Clinical Trials | eviCore Webinar Series ( Download)
